Anaptysbio (ANAB) Profit After Tax Growth (3y) (2019 - 2026)
Anaptysbio (ANAB) Profit After Tax Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 9.53% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 38.43% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 13.80% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -27.65% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 70.25% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Anaptysbio | 1.54 Bn | 1.26 Bn | - | -6.20% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.20% |
| Dec 31, 2025 | 63.64% |
| Sep 30, 2025 | 34.33% |
| Jun 30, 2025 | -5.87% |
| Mar 31, 2025 | -2.88% |
| Dec 31, 2024 | 12.89% |
| Sep 30, 2024 | -67.92% |
| Jun 30, 2024 | -377.34% |
| Mar 31, 2024 | -34.24% |
| Dec 31, 2023 | -48.39% |
| Sep 30, 2023 | -15.42% |
| Jun 30, 2023 | -22.74% |
| Mar 31, 2023 | -74.97% |
| Dec 31, 2022 | -0.92% |
| Sep 30, 2022 | -4.62% |
| Jun 30, 2022 | -10.75% |
| Mar 31, 2022 | -17.98% |
| Dec 31, 2021 | -25.20% |
| Sep 30, 2021 | 24.94% |
| Jun 30, 2021 | 68.42% |